| Dr Gustavo V Villegas, MD | |
|
2603 Michael Angelo Dr, Edinburg, TX 78539-1417 | |
| (956) 362-8767 | |
| (956) 362-2548 |
| Full Name | Dr Gustavo V Villegas |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 14 Years |
| Location | 2603 Michael Angelo Dr, Edinburg, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710207378 | NPI | - | NPPES |
| 349165602 | Medicaid | TX | |
| 349165601 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | Q5296 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doctors Hospital At Renaissance | Edinburg, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Renaissance Surgery Group | 9234384769 | 11 |
News Archive
Bioness Inc., today announced the commercial release of its NESS L300 Plus System. Cleared by the U.S. Food and Drug Administration (FDA) earlier this year, the L300 Plus combines the award winning NESS L300 Foot Drop System with a thigh cuff to activate even more of the nerves and muscles in the leg for greater control while walking.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the U.S. Food and Drug Administration has completed its review of ACADIA's Investigational New Drug application to begin Phase I clinical studies with AM-831, an innovative small molecule for the treatment of schizophrenia.
A shortened version of a questionnaire used by psychologists to assess risk factors for obsessive-compulsive disorder also may help determine the risk of depression and anxiety, according to a Baylor University study.
New drivers between the ages of 15 and 25 account for nearly half of the more than one million road deaths that occur worldwide each year, according to the World Health Organization. Educational programs often use fear-based messaging and films of crash scenes to reduce risky driving behavior among young people.
› Verified 9 days ago
| Entity Name | Renaissance Surgery Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215289129 PECOS PAC ID: 9234384769 Enrollment ID: O20130306000347 |
News Archive
Bioness Inc., today announced the commercial release of its NESS L300 Plus System. Cleared by the U.S. Food and Drug Administration (FDA) earlier this year, the L300 Plus combines the award winning NESS L300 Foot Drop System with a thigh cuff to activate even more of the nerves and muscles in the leg for greater control while walking.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the U.S. Food and Drug Administration has completed its review of ACADIA's Investigational New Drug application to begin Phase I clinical studies with AM-831, an innovative small molecule for the treatment of schizophrenia.
A shortened version of a questionnaire used by psychologists to assess risk factors for obsessive-compulsive disorder also may help determine the risk of depression and anxiety, according to a Baylor University study.
New drivers between the ages of 15 and 25 account for nearly half of the more than one million road deaths that occur worldwide each year, according to the World Health Organization. Educational programs often use fear-based messaging and films of crash scenes to reduce risky driving behavior among young people.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gustavo V Villegas, MD 2603 Michael Angelo Dr, Edinburg, TX 78539-1417 Ph: (956) 362-8767 | Dr Gustavo V Villegas, MD 2603 Michael Angelo Dr, Edinburg, TX 78539-1417 Ph: (956) 362-8767 |
News Archive
Bioness Inc., today announced the commercial release of its NESS L300 Plus System. Cleared by the U.S. Food and Drug Administration (FDA) earlier this year, the L300 Plus combines the award winning NESS L300 Foot Drop System with a thigh cuff to activate even more of the nerves and muscles in the leg for greater control while walking.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the U.S. Food and Drug Administration has completed its review of ACADIA's Investigational New Drug application to begin Phase I clinical studies with AM-831, an innovative small molecule for the treatment of schizophrenia.
A shortened version of a questionnaire used by psychologists to assess risk factors for obsessive-compulsive disorder also may help determine the risk of depression and anxiety, according to a Baylor University study.
New drivers between the ages of 15 and 25 account for nearly half of the more than one million road deaths that occur worldwide each year, according to the World Health Organization. Educational programs often use fear-based messaging and films of crash scenes to reduce risky driving behavior among young people.
› Verified 9 days ago
Dr. Rex B Kare, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2123 Cornerstone Blvd, Edinburg, TX 78539 Phone: 956-630-4944 Fax: 956-630-4464 | |
Dr. Stylianos Sideris, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2603 Michaelangelo Dr, Edinburg, TX 78539 Phone: 956-362-8767 Fax: 956-362-2548 | |
Amanda Lynne Mure, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2603 Michaelangelo Dr, Edinburg, TX 78539 Phone: 956-362-8767 Fax: 956-362-3614 | |
Henry E Ruiz, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2603 Michael Angelo Dr, Edinburg, TX 78539 Phone: 956-362-8767 Fax: 956-362-2548 | |
Dr. Manuel George Espinoza, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2603 Michael Angelo Dr, Edinburg, TX 78539 Phone: 956-362-8767 Fax: 956-362-2548 | |
Dr. Diego Andres Aguilar Palacios, M.D Urology Medicare: Accepting Medicare Assignments Practice Location: 2603 Michaelangelo Dr, Edinburg, TX 78539 Phone: 956-362-8767 Fax: 956-362-2548 | |
Alexander J Feigl, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2603 Michael Angelo Dr, Edinburg, TX 78539 Phone: 956-362-8767 Fax: 956-362-2548 |